Adding New Vaccine Type to Leading Immunotherapy Dramatically Reduced Melanoma Recurrence

NEW YORK, April 16, 2023 /PRNewswire/ -- The combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of melanoma recurring or causing death by 44% when compared to immunotherapy alone, a new clinical trial shows. Led by researchers at NYU Langone Health...